Developing and Scaling COVID-19 Vaccines May 13, 2020 at 12:30 – 2:30 pm ET A webinar by the Duke-Margolis Center for Health Policy and the Alexandria Summit Objective: To explore issues, strategies, and policies for developing and scaling COVID-19 vaccines. 12:30 pm Welcome and Overview Mark McClellan, Duke-Margolis Center for Health Policy 12:45 pm Fireside Chat Mark McClellan, Duke-Margolis Center for Health Policy Anthony Fauci, National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services 1:00 pm Envisioning a Path Forward Remarks from Scott Gottlieb, American Enterprise Institute and former Food and Drug Administration, U.S. Department of Health and Human Services 1:05 pm Session One: Vaccine Development This session will explore vaccine development under an accelerated timeline, including strategies to develop or modify technologies, participate in cross-sector collaborations, conduct clinical trials, and achieve approval – all during an active pandemic. Peter Marks, Center for Biologics Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services Tal Zaks, Moderna Therapeutics Adrian Hill, Jenner Institute and Oxford Martin Programme on Vaccines John Reed, Sanofi 1:45 pm Session Two: Vaccine Production and Access at Scale This session will explore the scope and scale of manufacturing needs, once a vaccine has been developed and approved, to prepare for demand and ensure appropriate access. Luciana Borio, In-Q-Tel and former National Security Council Director, Medical and Biodefense Preparedness Paul Stoffels, Johnson & Johnson Richard J. Hatchett, Coalition for Epidemic Preparedness Innovation Victor Dzau, National Academy of Medicine 2:25 pm Closing Remarks Joel Marcus, Alexandria Summit; Alexandria Real Estate Equities, Inc./Alexandria Venture Investments Lynne Zydowsky, Alexandria Summit; Alexandria Real Estate Equities, Inc./Alexandria Venture Investments Mark McClellan, Duke-Margolis Center for Health Policy 2:30 pm Adjourn .